img

Post-pandemic Era-Global Bulk Drug Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2034


Published on: 2024-01-04 | No of Pages : 334 | Industry : Pharma & Healthcare Research Center

Publisher : MRA | Format : PDF

Post-pandemic Era-Global Bulk Drug Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2034

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales.MRA published a report for global Bulk Drug market in this environment.

In terms of revenue, this research report indicated that the global Bulk Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Bulk Drug industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Teva aims at producing XX Bulk Drug in 2020, with XX % production to take place in global market, Novartis accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Bulk Drug Market byMRA Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Bulk Drug Market?
Teva
Novartis
Pfizer
Johnson and Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
...
Major Type of Bulk Drug Covered inMRA report
Vitamin
Antibiotic
Iohexol
Hormone
Amino Acid
Application Segments Covered inMRA Market
Orthopedics Disease
Others
Application 3

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Bulk Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Vitamin -Product Introduction and Major Manufacturers
1.1.2 Antibiotic -Product Introduction and Major Manufacturers
1.1.3 Iohexol -Product Introduction and Major Manufacturers
1.1.4 Hormone -Product Introduction and Major Manufacturers
1.1.5 Amino Acid -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Bulk Drug Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Bulk Drug Market
3.1.1 Top Companies leading Bulk Drug Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Bulk Drug Market
3.2.1 Top Companies leading Bulk Drug Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Bulk Drug Market
3.3.1 Top Companies leading Bulk Drug Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Bulk Drug Market
3.4.1 Top Companies leading Bulk Drug Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Bulk Drug Market
3.5.1 Top Companies leading Bulk Drug Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Bulk Drug Market
3.6.1 Top Companies leading Bulk Drug Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Bulk Drug Market
3.7.1 Top Companies leading Bulk Drug Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Bulk Drug Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Bulk Drug Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Bulk Drug Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Bulk Drug Sales and Growth Rate (2021-2026)
5.2 Global Bulk Drug Sales Value and Growth Rate (2021-2026)

6 Bulk Drug Competitive Analysis
6.1 Teva
6.1.1 Teva Company Profiles
6.1.2 Teva Product Introduction
6.1.3 Teva Bulk Drug Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Novartis
6.2.1 Novartis Company Profiles
6.2.2 Novartis Product Introduction
6.2.3 Novartis Bulk Drug Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Pfizer
6.3.1 Pfizer Company Profiles
6.3.2 Pfizer Product Introduction
6.3.3 Pfizer Bulk Drug Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Johnson and Johnson
6.4.1 Johnson and Johnson Company Profiles
6.4.2 Johnson and Johnson Product Introduction
6.4.3 Johnson and Johnson Bulk Drug Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Mylan
6.5.1 Mylan Company Profiles
6.5.2 Mylan Product Introduction
6.5.3 Mylan Bulk Drug Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 North China Pharmaceutical Group
6.6.1 North China Pharmaceutical Group Company Profiles
6.6.2 North China Pharmaceutical Group Product Introduction
6.6.3 North China Pharmaceutical Group Bulk Drug Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Dr. Reddy’s Laboratories
6.7.1 Dr. Reddy’s Laboratories Company Profiles
6.7.2 Dr. Reddy’s Laboratories Product Introduction
6.7.3 Dr. Reddy’s Laboratories Bulk Drug Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Roche
6.8.1 Roche Company Profiles
6.8.2 Roche Product Introduction
6.8.3 Roche Bulk Drug Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Aurobindo pharma
6.9.1 Aurobindo pharma Company Profiles
6.9.2 Aurobindo pharma Product Introduction
6.9.3 Aurobindo pharma Bulk Drug Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Sun Pharmaceutical Industries
6.10.1 Sun Pharmaceutical Industries Company Profiles
6.10.2 Sun Pharmaceutical Industries Product Introduction
6.10.3 Sun Pharmaceutical Industries Bulk Drug Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Boehringer Ingelheim GmbH
6.12 Bayer
6.13 BASF
6.14 DSM
6.15 Zhejiang Medicine
6.16 Biocon
6.17 Johnson Matthey
6.18 Hisun Pharmacy
6.19 Cambrex
6.20 Shandong Xinhua Pharmaceutical
6.21 Lonza group
6.22 Huahai Pharmaceutical
6.23 Haerbin Pharmaceutical Group
7 Conclusion


List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Bulk Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Bulk Drug Sales (K Unit) by Type (2015-2026)
Figure Global Bulk Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Bulk Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Bulk Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Bulk Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Bulk Drug Sales (K Unit) by Application (2015-2026)
Table China Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table China Bulk Drug Sales Market Share of Major Company (2015-2020)
Table China Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure China Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table China Bulk Drug Sales Value Share of Major Company (2015-2020)
Table China Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table China Bulk Drug Sales (Unit) by Type (2015-2026)
Figure China Bulk Drug Sales (Unit) by Type (2015-2026)
Table EU Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table EU Bulk Drug Sales Market Share of Major Company (2015-2020)
Table EU Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure EU Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table EU Bulk Drug Sales Value Share of Major Company (2015-2020)
Table EU Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table EU Bulk Drug Sales (Unit) by Type (2015-2026)
Figure EU Bulk Drug Sales (Unit) by Type (2015-2026)
Table USA Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table USA Bulk Drug Sales Market Share of Major Company (2015-2020)
Table USA Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure USA Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table USA Bulk Drug Sales Value Share of Major Company (2015-2020)
Table USA Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table USA Bulk Drug Sales (Unit) by Type (2015-2026)
Figure USA Bulk Drug Sales (Unit) by Type (2015-2026)
Table Japan Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table Japan Bulk Drug Sales Market Share of Major Company (2015-2020)
Table Japan Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure Japan Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table Japan Bulk Drug Sales Value Share of Major Company (2015-2020)
Table Japan Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table Japan Bulk Drug Sales (Unit) by Type (2015-2026)
Figure Japan Bulk Drug Sales (Unit) by Type (2015-2026)
Table India Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table India Bulk Drug Sales Market Share of Major Company (2015-2020)
Table India Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure India Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table India Bulk Drug Sales Value Share of Major Company (2015-2020)
Table India Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table India Bulk Drug Sales (Unit) by Type (2015-2026)
Figure India Bulk Drug Sales (Unit) by Type (2015-2026)
Table Southeast Asia Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table Southeast Asia Bulk Drug Sales Market Share of Major Company (2015-2020)
Table Southeast Asia Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure Southeast Asia Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table Southeast Asia Bulk Drug Sales Value Share of Major Company (2015-2020)
Table Southeast Asia Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table Southeast Asia Bulk Drug Sales (Unit) by Type (2015-2026)
Figure Southeast Asia Bulk Drug Sales (Unit) by Type (2015-2026)
Table South America Bulk Drug Sales (K Unit) of Major Company (2015-2020)
Table South America Bulk Drug Sales Market Share of Major Company (2015-2020)
Table South America Bulk Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure South America Bulk Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table South America Bulk Drug Sales Value Share of Major Company (2015-2020)
Table South America Bulk Drug Price (USD/Unit), by Type (2019-2020)
Table South America Bulk Drug Sales (Unit) by Type (2015-2026)
Figure South America Bulk Drug Sales (Unit) by Type (2015-2026)
Figure Value Chain Structure of Bulk Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Bulk Drug
Figure Cost Structure of Bulk Drug in 2020
Table Distributors/Traders List
Table Regional Market Sales (K Unit) (2021-2026)
Table Regional Market Sales Share (2021-2026)
Figure Global Bulk Drug Sales (Unit), Growth Rate & Market Share (2021-2026)
Table Regional Market Sales Value (Million USD) (2021-2026)
Table Regional Market Sales Value Share (2021-2026)
Figure Global Bulk Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table Teva Profiles
Table Teva Bulk Drug Product Introduction
Table Teva Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Teva SWOT Analysis
Table Novartis Profiles
Table Novartis Bulk Drug Product Introduction
Table Novartis Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Novartis SWOT Analysis
Table Pfizer Profiles
Table Pfizer Bulk Drug Product Introduction
Table Pfizer Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Pfizer SWOT Analysis
Table Johnson and Johnson Profiles
Table Johnson and Johnson Bulk Drug Product Introduction
Table Johnson and Johnson Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Johnson and Johnson SWOT Analysis
Table Mylan Profiles
Table Mylan Bulk Drug Product Introduction
Table Mylan Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Mylan SWOT Analysis
Table North China Pharmaceutical Group Profiles
Table North China Pharmaceutical Group Bulk Drug Product Introduction
Table North China Pharmaceutical Group Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure North China Pharmaceutical Group SWOT Analysis
Table Dr. Reddy’s Laboratories Profiles
Table Dr. Reddy’s Laboratories Bulk Drug Product Introduction
Table Dr. Reddy’s Laboratories Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Dr. Reddy’s Laboratories SWOT Analysis
Table Roche Profiles
Table Roche Bulk Drug Product Introduction
Table Roche Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Roche SWOT Analysis
Table Aurobindo pharma Profiles
Table Aurobindo pharma Bulk Drug Product Introduction
Table Aurobindo pharma Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Aurobindo pharma SWOT Analysis
Table Sun Pharmaceutical Industries Profiles
Table Sun Pharmaceutical Industries Bulk Drug Product Introduction
Table Sun Pharmaceutical Industries Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Sun Pharmaceutical Industries SWOT Analysis
Table Boehringer Ingelheim GmbH Profiles
Table Boehringer Ingelheim GmbH Bulk Drug Product Introduction
Table Boehringer Ingelheim GmbH Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Boehringer Ingelheim GmbH SWOT Analysis
Table Bayer Profiles
Table Bayer Bulk Drug Product Introduction
Table Bayer Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Bayer SWOT Analysis
Table BASF Profiles
Table BASF Bulk Drug Product Introduction
Table BASF Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure BASF SWOT Analysis
Table DSM Profiles
Table DSM Bulk Drug Product Introduction
Table DSM Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure DSM SWOT Analysis
Table Zhejiang Medicine Profiles
Table Zhejiang Medicine Bulk Drug Product Introduction
Table Zhejiang Medicine Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Zhejiang Medicine SWOT Analysis
Table Biocon Profiles
Table Biocon Bulk Drug Product Introduction
Table Biocon Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Biocon SWOT Analysis
Table Johnson Matthey Profiles
Table Johnson Matthey Bulk Drug Product Introduction
Table Johnson Matthey Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Johnson Matthey SWOT Analysis
Table Hisun Pharmacy Profiles
Table Hisun Pharmacy Bulk Drug Product Introduction
Table Hisun Pharmacy Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Hisun Pharmacy SWOT Analysis
Table Cambrex Profiles
Table Cambrex Bulk Drug Product Introduction
Table Cambrex Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Cambrex SWOT Analysis
Table Shandong Xinhua Pharmaceutical Profiles
Table Shandong Xinhua Pharmaceutical Bulk Drug Product Introduction
Table Shandong Xinhua Pharmaceutical Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Shandong Xinhua Pharmaceutical SWOT Analysis
Table Lonza group Profiles
Table Lonza group Bulk Drug Product Introduction
Table Lonza group Bulk Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Lonza group SWOT Analysis
Table Huahai Pharmaceutical Profiles